Dysport Injection (Clostridium botulinum type A toxin-haemagglutinin complex)
Dysport is a medication that contains Clostridium botulinum type A toxin-haemagglutinin complex, commonly used to treat various medical conditions, including muscle spasms and cosmetic concerns such as wrinkles.
Product Overview
Dysport Injection is a highly specialized, neuromuscular blocking agent formulated for targeted intramuscular, intradermal, or intradetrusor administration. Containing a precise Clostridium botulinum type A toxin-haemagglutinin complex, this advanced biologic therapy is clinically deployed to treat severe focal spasticity, movement disorders, and localized autonomic hyperactivity. By temporary and selective disruption of nerve-to-muscle signaling, it provides crucial therapeutic relief for complex chronic conditions when systemic muscle relaxants fall short or present intolerable side effects.
Product Composition
- Active Pharmaceutical Ingredient: Contains abobotulinumtoxinA (as a structural Clostridium botulinum type A toxin-haemagglutinin complex) at a concentration of 500 Units per vial.
- Therapeutic Formula Class: Neuromuscular blocking agent; acetylcholine release inhibitor.
- Stabilizing Matrix: Formulated in a sterile, preservative-free lyophilized (freeze-dried) powder cake alongside 125 micrograms of human serum albumin and 2.5mg of lactose.
- Potency Non-Interchangeability: The potency units of Dysport are specific to its proprietary biological assay method. They are not interchangeable with, nor can they be converted into, units of any other botulinum toxin preparations (such as Botox or Xeomin).
Product Specification
| Attribute | Specification |
| Brand Identity | Dysport Therapeutic / Dysport Aesthetic |
| Generic Substance | AbobotulinumtoxinA |
| Concentration Strengths | 500 Units per single-use vial |
| Primary Therapeutic Indications | Focal adult spasticity (upper/lower limbs), pediatric cerebral palsy spasticity |
| Secondary & Aesthetic Indications | Severe axillary hyperhidrosis, blepharospasm, hemifacial spasm, and moderate-to-severe glabellar/crow's feet lines |
Mechanism of Action
- Neuromuscular Junction Targeting: Following local injection into muscle or tissue, the 900,000-Dalton macromolecular protein complex dissociates, freeing the active neurotoxin component to bind rapidly and specifically to high-affinity receptors on cholinergic nerve endings.
- SNARE Complex Cleavage: The toxin is internalized into the nerve terminal, where its light chain acts as a zinc-dependent endopeptidase to selectively cleave SNAP-25—an essential protein in the SNARE complex required for cellular transport.
- Acetylcholine Inhibition: By destroying the SNAP-25 gateway, the neurotoxin completely blocks the calcium-regulated release of acetylcholine into the synaptic cleft, neutralizing the chemical trigger that commands muscles to contract or sweat glands to secrete.
- Functional Flaccid Paralysis: The targeted muscle enters a state of localized, temporary relaxation. Over a period of 12 to 24 weeks, the nerve terminal gradually sprouts new nerve endings and synthesizes fresh SNARE proteins, slowly restoring normal transmission.
Key Benefits
- Localized, Non-Systemic Control: Delivers intensive spasm or hyperhidrosis control strictly within the injected anatomical zone, leaving the rest of the body's muscle tone and systemic pathways entirely unaffected.
- High Tissue Migration and Distribution: The unique biochemical configuration of abobotulinumtoxinA allows for a predictable, effective spread across larger hyperactive muscle groups, such as the hamstrings, gastrocnemius, or shoulder girdles.
- Sustained Therapeutic Longevity: A single multi-point injection session routinely yields profound, continuous clinical improvements that persist for 3 to 6 months, drastically minimizing the annual treatment burden for chronic patients.
- Significant Quality-of-Life Gains: Directly reduces painful muscle contractures and dynamic deformities (such as equinus foot in pediatric cerebral palsy), facilitating successful physical therapy, improved gait, and ease of daily hygiene.
Precautions
Dysport Injection (Clostridium botulinum type A toxin-haemagglutinin complex) should be used carefully to ensure safe and effective results in both cosmetic and medical treatments.
| Precaution | Details |
|---|---|
| Neuromuscular Disorders | Use with caution in muscle-related diseases. |
| Pregnancy & Breastfeeding | Use only after medical advice. |
| Infection at Site | Avoid injection in infected areas. |
| Allergic History | Avoid if allergic to botulinum toxin. |
| Eye Disorders | Extra caution for facial injections near eyes. |
| Driving | May cause temporary muscle weakness. |
| Repeated Use | Overuse may reduce effectiveness. |
Important Safety Advice
- Administer only by trained healthcare professional
- Do not self-inject under any circumstances
- Avoid rubbing or massaging treated area
- Follow recommended dose and treatment interval
- Inform about all existing medical conditions
When Extra Care Is Needed
- History of swallowing or breathing problems
- Muscle weakness disorders
- Facial nerve or eye-related conditions
- Previous reactions to botulinum toxin products
Usage
Because this biological product contains an active neurotoxin, preparation and clinical administration require precise handling. This medication must only be prepared and delivered by a qualified healthcare professional who has specific training in neuromuscular mapping and localized injection techniques.
Reconstitution Rules: The lyophilized powder must be carefully dissolved using sterile, preservative-free 0.9% Sodium Chloride Injection. The diluent must be introduced gently into the vial to avoid foaming, which can break down the fragile protein complex.
Prompt Administration: Once mixed with saline, the solution contains no preservatives. It should be administered immediately or stored in a refrigerator at 2°C to 8°C and used within 24 hours of mixing. Any remaining solution must be discarded safely as biohazardous waste.
Anatomical Targeting Guidance: To maximize precision and avoid unwanted muscle weakness in surrounding tissues, clinicians routinely use electromyography (EMG), electrical stimulation, or ultrasound guidance to locate the exact overactive muscle bellies.
Multi-Point Delivery: The total calculated dose for a target muscle is rarely given in a single injection. Instead, it is divided into multiple small injection points across the muscle tissue to ensure even distribution and effective muscle relaxation.
Uses
Dysport Injection is a highly versatile therapy used across multiple medical specialties. The clinical AbobotulinumtoxinA uses target pathologically hyperactive muscles and localized glandular overactivity.
Management of Adult Focal Spasticity: Prescribed to reduce severe muscle stiffness and muscle contractures in the upper limbs (such as a clenched fist or flexed wrist) and lower limbs (such as an inverted ankle or stiff calf) following a stroke, traumatic brain injury, or multiple sclerosis.
Treatment of Pediatric Cerebral Palsy Spasticity: Indicated for children aged two years and older to treat dynamic equinus foot deformity caused by spasticity, helping to improve their overall walking gait and physical therapy outcomes.
Correction of Cervical Dystonia: Deployed to treat spasmodic torticollis in adults, reducing the painful, involuntary muscle contractions that cause abnormal neck twisting and head positioning.
Control of Severe Axillary Hyperhidrosis: Injected intradermally into the armpits to provide long-lasting relief from severe, continuous sweating when standard extra-strength antiperspirants fail to manage the condition.
Resolution of Blepharospasm and Hemifacial Spasm: Used to halt involuntary, rapid twitching of the eyelids and uncoordinated contractions of the facial muscles on one side of the face.
Aesthetic Facial Rejuvenation: Administered in cosmetic dermatology to temporarily smooth out moderate-to-severe glabellar lines (frown lines between the eyebrows) and lateral canthal lines (crow's feet around the eyes).
Side Effects
Dysport Injection (Clostridium botulinum type A toxin-haemagglutinin complex) may cause side effects. Most are mild and temporary, but some may require medical attention.
| Side Effect | Details |
|---|---|
| Injection Site Pain | Mild pain or discomfort. |
| Swelling | Local swelling at injection area. |
| Bruising | Mild bruising may occur. |
| Headache | Temporary headache. |
| Muscle Weakness | Mild weakness near treated area. |
| Drooping Eyelid | May occur in facial treatments. |
| Flu-like Symptoms | Mild tiredness or body ache. |
Common Side Effects
- Pain or redness at injection site
- Mild swelling or bruising
- Headache
- Temporary muscle weakness
- Flu-like feeling
Less Common Effects
- Drooping eyelid or asymmetry
- Dry eyes or tearing (facial use)
- Mild fatigue
- Neck or localized muscle discomfort
Serious Side Effects (Seek Medical Help)
- Difficulty swallowing or breathing
- Severe muscle weakness
- Spread of toxin effects beyond treated area
- Severe allergic reactions like rash, swelling, or dizziness
FAQs
Q: What is the product used for? A: Dysport Injection is a prescription medicine containing abobotulinumtoxinA, a specialized nerve-blocking protein. In therapeutic medicine, it is injected into muscles to treat severe muscle stiffness and spasms (focal spasticity) in adults and children with cerebral palsy, as well as abnormal neck positioning (cervical dystonia).
Q: Are the units of Dysport identical to other botulinum toxin products? A: No. The biological potency units of this medication are entirely unique to its specific manufacturing and testing methods. They are not interchangeable with other botulinum toxin brands, such as Botox or Xeomin.
Q: How is this treatment administered?
A: This medicine is a sterile powder that must be reconstituted with preservative-free normal saline by a qualified healthcare professional. It is administered via precise intramuscular, intradermal, or intradetrusor injections directly into the affected muscle groups or skin tissues using specialized anatomical mapping or electromyography (EMG) guidance.
Q: How long does it take to see results, and how long do they last?
A: For muscle spasticity and dystonia, initial muscle relaxation typically begins within 2 to 7 days after the injection session. The maximum therapeutic effect is usually achieved within 2 to 4 weeks, and the clinical benefits generally last between 3 to 6 months, after which symptoms will slowly return and a repeat treatment may be scheduled.
Q: What are the most common side effects?
A: The most frequent side effects include localized pain, bruising, swelling, or muscle weakness at the injection site. Some patients may also experience mild flu-like symptoms, fatigue, or a headache shortly after the procedure. When used near the eyes or face, temporary eyelid drooping (ptosis) or dry eyes can occur.
Q: Is there a risk of the toxin spreading away from the injection site?
A: Yes, all botulinum toxin products carry a black-box warning regarding the potential for the toxin to spread to other areas of the body. While rare when administered at correct therapeutic doses, this can cause serious symptoms such as difficulty swallowing, trouble speaking, generalized muscle weakness, or breathing difficulties.
Q: Who should avoid receiving this injection?
A: You should not receive this treatment if you have a known allergy to botulinum toxin or any components of the matrix (such as cow's milk proteins or human serum albumin), or if there is an active infection at the planned injection site.
Interactions
Dysport Injection (Clostridium botulinum type A toxin-haemagglutinin complex) may interact with certain medicines that affect nerve or muscle function. These interactions can increase side effects like muscle weakness.
| Interaction Type | Details |
|---|---|
| Aminoglycoside Antibiotics | May increase muscle weakness. |
| Muscle Relaxants | Can enhance muscle paralysis effect. |
| Anticholinergic Drugs | May increase side effects. |
| Other Botulinum Toxins | Risk of additive effects. |
| Blood Thinners | May increase bruising at injection site. |
| Neuromuscular Disorders Medicines | Can worsen muscle weakness. |
| Anesthesia Agents | May enhance neuromuscular effects. |
Medicines That May Interact
- Aminoglycosides like gentamicin
- Muscle relaxants used in surgery
- Anticholinergic medicines
- Other botulinum toxin products
- Blood thinning medicines
Important Considerations
- Inform about all medicines before treatment
- Avoid combining with similar neurotoxin products
- Use caution if undergoing surgery or anesthesia
- Monitor for excessive muscle weakness
- Ensure treatment is done only by trained professionals
| Manufacturer | : | Bharat Serum, India |
| Trade Name | : | |
| Generic Search | : | Clostridium botulinum type A toxin-haemagglutinin complex |
| Strength | : | 500IU |















